Skip to content
Search
Search
Find an RVT
Contact
Member Log In
Find an RVT
Contact Us
Member Login
About OAVT
What is an RVT?
History of the OAVT
Legislative Reform
Board of Directors
Become an OAVT Director
OAVT Strategic Plan 2022-2025
OAVT By-law and Policies
OAVT By-law
OAVT Regulation Policies
The OAVT Complaints Process
Rabies Response Program
Partner with Us
Become an RVT
Steps to Become an RVT
Professionalism & Ethics Workshop
OAVT Accredited Colleges
Membership Benefits & Pricing
Apply
For Members
Continuing Education (CE)
The OAVT’s Recognition Program
Membership Renewals
Membership Renewals FAQs
Member Resources
Wellness Resources
Volunteer Opportunities
OAVT Marketplace
Jobs
Job Search
Post A Job
My Job Ads
Posting a Job Ad FAQs
Locum Listings
Post a Locum Listing
Events
Event Calendar
My Event Posts
Accredit Your Event
OAVT Conference
RVTMonth
News & Resources
Press Releases
RVT Journal
Advertise
Contribute
Subscribe
Value of an RVT Study
Become a Member
Find an RVT
Contact Us
Member Login
About OAVT
What is an RVT?
History of the OAVT
Legislative Reform
Board of Directors
Become an OAVT Director
OAVT Strategic Plan 2022-2025
OAVT By-law and Policies
OAVT By-law
OAVT Regulation Policies
The OAVT Complaints Process
Rabies Response Program
Partner with Us
Become an RVT
Steps to Become an RVT
Professionalism & Ethics Workshop
OAVT Accredited Colleges
Membership Benefits & Pricing
Apply
For Members
Continuing Education (CE)
The OAVT’s Recognition Program
Membership Renewals
Membership Renewals FAQs
Member Resources
Wellness Resources
Volunteer Opportunities
OAVT Marketplace
Jobs
Job Search
Post A Job
My Job Ads
Posting a Job Ad FAQs
Locum Listings
Post a Locum Listing
Events
Event Calendar
My Event Posts
Accredit Your Event
OAVT Conference
RVTMonth
News & Resources
Press Releases
RVT Journal
Advertise
Contribute
Subscribe
Value of an RVT Study
Become a Member
Search
Menu
Find an RVT
Contact Us
Member Login
About OAVT
What is an RVT?
History of the OAVT
Legislative Reform
Board of Directors
Become an OAVT Director
OAVT Strategic Plan 2022-2025
OAVT By-law and Policies
OAVT By-law
OAVT Regulation Policies
The OAVT Complaints Process
Rabies Response Program
Partner with Us
Become an RVT
Steps to Become an RVT
Professionalism & Ethics Workshop
OAVT Accredited Colleges
Membership Benefits & Pricing
Apply
For Members
Continuing Education (CE)
The OAVT’s Recognition Program
Membership Renewals
Membership Renewals FAQs
Member Resources
Wellness Resources
Volunteer Opportunities
OAVT Marketplace
Jobs
Job Search
Post A Job
My Job Ads
Posting a Job Ad FAQs
Locum Listings
Post a Locum Listing
Events
Event Calendar
My Event Posts
Accredit Your Event
OAVT Conference
RVTMonth
News & Resources
Press Releases
RVT Journal
Advertise
Contribute
Subscribe
Value of an RVT Study
Become a Member
Search
Go
RVT Journal Quiz: Volume 47, Issue 1, Article 2 – Cutaneous Lymphoma
Name
*
Name
First
First
Last
Last
Email
*
Member Number
*
1. A patient with stage II multicentric lymphoma would involve which of the following?
*
a. multiple peripheral lymph nodes on one side of the diaphragm
b. involvement of liver and spleen
c. involvement of the bone marrow
d. a generalized lymphadenopathy
2. Large cell lymphoma is slower to progress than small cell lymphoma.
*
a. true
b. false
3. The gold standard treatment for multicentric lymphoma is a combination of drugs known by the acronym:
*
a. CHOP
b. MOPP
c. LOPP
d. CHPP
4. Lymphoma can present in which of the following organs of the body?
*
a. eyes
b. nasal cavity
c. skin
d. all of the above
5. Mycosis Fungoides (a rare skin cancer affecting people) is most like which of the following?
*
a. Sezary syndrome
b. epitheliotropic lymphoma
c. pagetoid reticulosis
d. non-epitheliotropic lymphoma
6. Definitive diagnosis for cutaneous lymphoma can be made via:
*
a. cytology
b. histopathology
c. blood test
d. impression smears
7. Chronic administration of lomustine can lead to which of the following laboratory abnormalities?
*
a. azotemia
b. hypercalcemia
c. hypernatremia
d. elevated hepatic enzymes
8. The most significant risk associated with L-asparaginase is:
*
a. bone marrow suppression
b. hypersensitivity reaction
c. extravasation injury
d. gastrointestinal upset
9. Which organ of the body is affected by cumulative doses of doxorubicin?
*
a. liver
b. heart
c. spleen
d. stomach
10. First line therapy for most forms of cutaneous lymphoma is typically achieved via which of the following?
*
a. safflower oil
b. radiotherapy
c. prednisone
d. lomustine
If you are human, leave this field blank.
Submit
Scroll Up